⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15039162 | 0.75 | — | — | |
| SCHEMBL1458149 | 0.75 | — | — | |
| SCHEMBL1047508 | 0.75 | — | — | |
| SCHEMBL9607550 | 0.71 | CA12 (0.34) | — | |
| SCHEMBL4550108 | 0.71 | — | — | |
| SCHEMBL15102119 | 0.71 | — | — | |
| SCHEMBL12955120 | 0.70 | LMNA (0.44) | — | |
| SCHEMBL9606754 | 0.70 | CA12 (0.33) | — | |
| SCHEMBL9209123 | 0.69 | — | — | |
| SCHEMBL16013391 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 408 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108780917-B | Rechargeable sodium cell for high energy density batteries | 博比特电池有限公司 | 2022-03-15 | — | — | CN | claimed |
| CN-110724276-B | Preparation method of acid-alkali difunctional MOFs material and method for synthesizing 3, 4-dimethylfurazan by using acid-alkali difunctional MOFs material as catalyst | 中国科学院青岛生物能源与过程研究所 | 2021-10-08 | — | — | CN | claimed |
| US-20200058958-A1 | RECHARGEABLE SODIUM CELLS FOR HIGH ENERGY DENSITY BATTERY USE | BROADBIT BATTERIES OY (FI) | 2020-02-20 | — | — | US | claimed |
| CN-110724276-A | Preparation method of acid-alkali difunctional MOFs material and method for synthesizing 3, 4-dimethylfurazan by using acid-alkali difunctional MOFs material as catalyst | 中国科学院青岛生物能源与过程研究所 | 2020-01-24 | — | — | CN | claimed |
| CN-108780917-A | Rechargeable sode cell unit for high energy density cells | 博比特电池有限公司 | 2018-11-09 | — | — | CN | claimed |
| EP-2794573-B1 | NOVEL INSECTICIDAL AROMATIC AMIDES | BAYER IP GMBH (DE) | 2017-08-30 | — | — | EP | claimed |
| US-9204645-B2 | Insecticidal aromatic amides | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2015-12-08 | — | — | US | claimed |
| EP-2350090-B1 | SPIRO-OXINDOLE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS | XENON PHARMACEUTICALS INC (CA) | 2015-06-03 | — | — | EP | claimed |
| US-20140371240-A1 | NOVEL INSECTICIDAL AROMATIC AMIDES | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2014-12-18 | — | — | US | claimed |
| EP-2794573-A1 | NOVEL INSECTICIDAL AROMATIC AMIDES | Bayer Intellectual Property GmbH (DE) | 2014-10-29 | — | — | EP | claimed |
| WO-2013092522-A1 | NOVEL INSECTICIDAL AROMATIC AMIDES | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2013-06-27 | — | — | WO | claimed |
| US-8263606-B2 | Spiro-oxindole compounds and their use as therapeutic agents | XENON PHARMACEUTICALS INC. (CA) | 2012-09-11 | — | — | US | claimed |
| EP-2350090-A2 | SPIRO-OXINDOLE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS | Xenon Pharmaceuticals Inc. (CA) | 2011-08-03 | — | — | EP | claimed |
| US-20100137299-A1 | SPIRO-OXINDOLE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS | XENON PHARMACEUTICALS INC. (CA) | 2010-06-03 | — | — | US | claimed |
| WO-2010045251-A2 | SPIRO-OXINDOLE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS | XENON PHARMACEUTICALS, INC. (CA) | 2010-04-22 | — | — | WO | claimed |
| CN-119698412-A | 5-HT2A receptor agonist, and preparation method and application thereof | 上海翊石医药科技有限公司 | 2025-03-25 | — | — | CN | disclosed |
| CN-119638629-A | Low-temperature molten salt, preparation method thereof and application method thereof in electrolytic aluminum | 安阳工学院 | 2025-03-18 | — | — | CN | disclosed |
| WO-2004058702-A2 | 4-[(4-(CARBOXYETHYL) PIPERIDINYL) METHYL] PYRROLIDINES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY | MERCK & CO., INC. (US) | 2004-07-15 | — | — | WO | disclosed |
| US-5877316-A | Morpholine derivatives, compositions containing them and their use as therapeutic agents | MERCK SHARP & DOHME LTD. (GB) | 1999-03-02 | — | — | US | disclosed |
| EP-0003329-A1 | Cephalexin-amide complex, process for its production and use in cephalexin-monohydrate production | BIOCHEMIE Gesellschaft m.b.H. (AT) | 1979-08-08 | — | — | EP | disclosed |